5 Stocks Under $10 Set to Soar
One under-$10 name that's trending very close to triggering a near-term breakout trade is ImmunoCellular Therapeutics (IMUC), which is seeking to develop and commercialize new therapeutics to fight cancer using the immune system. This stock is off to a decent start in 2013, with shares up 9%.
If you take a look at the chart for ImmunoCellular Therapeutics, you'll notice that this stock has been downtrending a bit for the last month, with shares dropping from a high of $2.28 to its recent low of $1.83 a share. During that downtrend, shares of IMUC have been consistently making lower highs and lower lows, which is bearish technical price action. That said, the stock has now started to move back above its 50-day moving average of $1.94 a share and it's quickly moving within range of triggering a near-term breakout trade.>>5 Stocks With Big Insider Buying Traders should now look for long-biased trades in IMUC if it manages to break out above some near-term overhead resistance levels at $2.20 to $2.28 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 533,470 shares. If that breakout hits soon, then IMUC will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $2.73 a share or at $2.93 to $2.94 a share. Any move above $2.94 will then put $3.26 to $3.50 into focus for shares of IMUC. Traders can look to buy IMUC off any weakness and simply use a stop that sits just below its 50-day moving average of $1.94 a share. One could also buy IMUC off strength once it clears those breakout levels with volume and then simply use a stop that sits just below $2 a share.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV